Microfluidic 3D hepatic cultures integrated with a droplet-based bioanalysis unit.

Automated microfluidics Glucose metabolism Hepatic spheroids In-droplet assay On-chip bioanalysis

Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
30 Nov 2023
Historique:
received: 06 08 2023
revised: 03 11 2023
accepted: 27 11 2023
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 4 1 2024
Statut: aheadofprint

Résumé

A common challenge in microfluidic cell cultures has to do with analysis of cell function without replacing a significant fraction of the culture volume and disturbing local concentration gradients of signals. To address this challenge, we developed a microfluidic cell culture device with an integrated bioanalysis unit to enable on-chip analysis of picoliter volumes of cell-conditioned media. The culture module consisted of an array of 140 microwells with a diameter of 300 m which were made low-binding to promote organization of cells into 3D spheroids. The bioanalysis module contained a droplet generator unit, 15 micromechanical valves and reservoirs loaded with reagents. Each 0.8 nL droplet contained an aliquot of conditioned media mixed with assay reagents. The use of microvalves allowed us to load enzymatic assay and immunoassay into sequentially generated droplets for detection of glucose and albumin, respectively. As a biological application of the microfluidic device, we evaluated hormonal stimulation and glucose consumption of hepatic spheroids. To mimic physiological processes occurring during feeding and fasting, hepatic spheroids were exposed to pancreatic hormones, insulin or glucagon. The droplet-based bioanalysis module was used to measure uptake or release of glucose upon hormonal stimulation. In the future, we intend to use this microfluidic device to mimic and measure pathophysiological processes associated with hepatic insulin resistance and diabetes in the context of metabolic syndrome.

Identifiants

pubmed: 38176252
pii: S0956-5663(23)00838-2
doi: 10.1016/j.bios.2023.115896
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115896

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jose M de Hoyos-Vega (JM)

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Alan M Gonzalez-Suarez (AM)

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Diana F Cedillo-Alcantar (DF)

Laboratory of Microtechnologies Applied to Biomedicine, Centro de Investigación y de Estudios Avanzados (Cinvestav), Monterrey, NL, Mexico.

Gulnaz Stybayeva (G)

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Aleksey Matveyenko (A)

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Harmeet Malhi (H)

Division of Gastroenterology and Hepatology, Mayo Clinic, MN, USA.

Jose L Garcia-Cordero (JL)

Laboratory of Microtechnologies Applied to Biomedicine, Centro de Investigación y de Estudios Avanzados (Cinvestav), Monterrey, NL, Mexico.

Alexander Revzin (A)

Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA. Electronic address: Revzin.Alexander@mayo.edu.

Classifications MeSH